Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI), covering 2025-08-14 to 2025-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old [Phase 1]